Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist

Nari Lee, Lida Zheng*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Purpose of Review: Toxic erythema of chemotherapy is an umbrella term for several non-allergic cutaneous reactions to chemotherapeutic agents. Given the heterogenous range of presentations, we will review the differential diagnoses and treatment approaches, particularly for hospitalized patients. Recent Findings: Early recognition, holding chemotherapy, or dose reduction and monitoring fluid balance for severely ill patients is the mainstay of treatment. Supportive care with topical steroids, emollients, and wound care have shown benefit. Summary: Toxic erythema of chemotherapy can mimic several common eruptions seen in oncologic patients. The recognition of both clinical and pathological features by inpatient dermatologists allows for appropriate management, and dose reduction if necessary, in order for patients to continue oncologic treatment.

Original languageEnglish (US)
Pages (from-to)222-231
Number of pages10
JournalCurrent Dermatology Reports
Issue number4
StatePublished - Dec 2021


  • Chemotherapy
  • Hand-foot syndrome
  • Oncodermatology
  • Toxic erythema of chemotherapy

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist'. Together they form a unique fingerprint.

Cite this